Longhorn Vaccines & Diagnostics Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year”

Longhorn Vaccines and Diagnostics Presents New Preclinical Data on Broad-Spectrum Anti-Bacterial Monoclonal Antibody LHNVD-501

Press Release

Mar 31

Written by Van Agens

Longhorn Vaccines and Diagnostics to Present New Data on DRG5‑BD11 Showing Broad Activity Against Multiple Bacterial Classes at ESCMID 2026

Longhorn Vaccines & Diagnostics' PrimeStore® MTM Validated with New Data for Large-Scale, Global TB Screening